Published in Ann Rheum Dis on July 01, 1995
Matrix metalloproteases: a role in overuse tendinopathies. Br J Sports Med (2005) 1.26
Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture. Clin Orthop Relat Res (2008) 1.25
Clinical and biological aspects of rotator cuff tears. Muscles Ligaments Tendons J (2013) 1.20
Prevalence and possible pathological significance of calcium phosphate salt accumulation in tendon matrix degeneration. Ann Rheum Dis (1996) 1.08
Tenascin-C and human tendon degeneration. Am J Pathol (1996) 1.06
Animal models for the study of tendinopathy. Br J Sports Med (2006) 1.04
Aprotinin in the management of Achilles tendinopathy: a randomised controlled trial. Br J Sports Med (2006) 1.04
Cell phenotypic variation in normal and damaged tendons. Int J Exp Pathol (2007) 1.03
Lysylhydroxylation and non-reducible crosslinking of human supraspinatus tendon collagen: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis (1999) 0.96
Metalloproteases and tendinopathy. Muscles Ligaments Tendons J (2013) 0.95
Multivariate analysis of biochemical markers in synovial fluid from the shoulder joint for diagnosis of rotator cuff tears. Rheumatol Int (2004) 0.93
Scaffold fiber diameter regulates human tendon fibroblast growth and differentiation. Tissue Eng Part A (2012) 0.92
Cycle-dependent matrix remodeling gene expression response in fatigue-loaded rat patellar tendons. J Orthop Res (2010) 0.87
Tendon lesions and soft tissue rheumatism--great outback or great opportunity? Ann Rheum Dis (1996) 0.87
Degenerative disease in rotator cuff tears: what are the biochemical and histological changes? Joints (2014) 0.84
Matrix metalloproteases and their inhibitors are altered in torn rotator cuff tendons, but also in the macroscopically and histologically intact portion of those tendons. Muscles Ligaments Tendons J (2013) 0.81
Do Matrix Metalloproteases and Tissue Inhibitors of Metalloproteases in Tenocytes of the Rotator Cuff Differ with Varying Donor Characteristics? Int J Mol Sci (2015) 0.75
Increased levels of the 14-3-3 η and γ proteins in the synovial fluid of dogs with unilateral cranial cruciate ligament rupture. Can J Vet Res (2011) 0.75
Matrix metalloproteinases: a review. Crit Rev Oral Biol Med (1993) 9.03
Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J (1991) 8.29
Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am (1991) 5.06
A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem (1979) 3.17
Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci U S A (1965) 2.61
Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis (1994) 1.73
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72
Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis (1994) 1.58
Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis (1994) 1.43
Release of collagenase, neutral protease, and prostaglandins from cultured mammalian synovial cells by hydroxyapatite and calcium pyrophosphate dihydrate crystals. Arthritis Rheum (1981) 1.40
Inhibitor of human collagenase from cultures of human tendon. J Biol Chem (1979) 1.32
The distribution of types I and III collagen and fibronectin in the healing equine tendon. Connect Tissue Res (1984) 1.28
Spatial relationships between fibroblasts during the growth of rat-tail tendon. Cell Tissue Res (1983) 1.12
Intrinsic flexor-tendon repair. A morphological study in vitro. J Bone Joint Surg Am (1984) 1.07
Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix (1992) 1.07
Experimental intrinsic healing of flexor tendons based upon synovial fluid nutrition. J Hand Surg Am (1978) 1.06
CRITICAL EVALUATION OF FLEXOR-TENDON HEALING AND ADHESION FORMATION WITHIN ARTIFICIAL DIGITAL SHEATHS. J Bone Joint Surg Am (1963) 0.98
A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions (1992) 0.94
Collagenases from periarticular ligaments and tendon: enzyme levels during the development of joint contracture. Matrix (1989) 0.87
Intrinsic tendon cell proliferation in tissue culture. J Hand Surg Am (1981) 0.86
Polyclonal and monoclonal antibodies against human tissue inhibitor of metalloproteinases (TIMP) and the design of an enzyme-linked immunosorbent assay to measure TIMP. Matrix (1991) 0.83
Isolation and growth characteristics of adult human tendon fibroblasts. Ann Rheum Dis (1987) 0.81
Collagenase production by rabbit ligaments and tendon. Connect Tissue Res (1988) 0.80
Inhibitors of collagenase in ligaments and tendons of rabbits immobilized for 4 weeks. Connect Tissue Res (1992) 0.79
Neutral metalloprotease from tendons. J Orthop Res (1989) 0.79
Collagen synthesis during primate flexor tendon repair in vitro. J Orthop Res (1990) 0.78
Shoulder disorders in the elderly: a community survey. Arthritis Rheum (1991) 3.21
A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem (1979) 3.17
Azathioprine in rheumatoid arthritis. Br Med J (1969) 3.14
Supervision of epileptic patients taking phenytoin. Br Med J (1970) 3.09
Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis (1981) 3.08
Thermographic changes in keyboard operators with chronic forearm pain. BMJ (1997) 2.90
Frozen shoulder: a long-term prospective study. Ann Rheum Dis (1984) 2.67
Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease. J Rheumatol (1974) 2.66
Frozen shoulder: prospective clinical study with an evaluation of three treatment regimens. Ann Rheum Dis (1984) 2.60
Shoulder disorders in the elderly (a hospital study). Ann Rheum Dis (1987) 2.45
Extracorporeal shock wave therapy for lateral epicondylitis--a double blind randomised controlled trial. J Orthop Res (2002) 2.40
Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature (1987) 2.40
Extracorporeal shock wave therapy for plantar fasciitis. A double blind randomised controlled trial. J Orthop Res (2003) 2.38
The painful stiff shoulder. Rheumatol Phys Med (1972) 2.37
Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J (1983) 2.17
Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12
Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94
A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. J Rheumatol (1990) 1.87
Wound healing after operations of patients with rheumatoid arthritis. J Bone Joint Surg Br (1973) 1.86
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis (1989) 1.81
Tennis elbow--a reappraisal. Br J Rheumatol (1989) 1.76
Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol (1997) 1.76
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis (1989) 1.74
An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology (Oxford) (2002) 1.74
Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis (1994) 1.73
Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet (1992) 1.72
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72
Extracorporeal shock-wave therapy for tendonitis of the rotator cuff. A double-blind, randomised, controlled trial. J Bone Joint Surg Br (2002) 1.71
The long-term outcome of rotator cuff tendinitis--a review study. Br J Rheumatol (1988) 1.69
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum (2001) 1.67
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis (1989) 1.66
Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol (1997) 1.64
Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62
The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1993) 1.62
Diagnosis and relation to general health of shoulder disorders presenting to primary care. Rheumatology (Oxford) (2005) 1.61
Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature (1987) 1.59
Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis (1994) 1.58
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57
Fragments of human fibroblast collagenase. Purification and characterization. Biochem J (1989) 1.55
Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis (1987) 1.54
The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum (1998) 1.53
Purification of pig synovial collagenase to high specific activity. Biochem J (1979) 1.53
The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum (2002) 1.52
An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J (1981) 1.52
Lateral humeral epicondylitis--a study of natural history and the effect of conservative therapy. Br J Rheumatol (1983) 1.46
Is therapeutic ultrasound effective in treating soft tissue lesions? Br Med J (Clin Res Ed) (1985) 1.46
Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure (1995) 1.44
Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis (1994) 1.43
Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis (1986) 1.42
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41
Immunological studies in frozen shoulder. J Rheumatol (1983) 1.38
Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer (1991) 1.34
Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax (2005) 1.33
Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum (2001) 1.31
Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum (1984) 1.31
Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis (2002) 1.31
Community survey of shoulder disorders in the elderly to assess the natural history and effects of treatment. Ann Rheum Dis (1995) 1.31
Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) (2005) 1.30
HLA-B27 and frozen shoulder. Lancet (1976) 1.29
A double-blind trial comparing subacromial methylprednisolone and lignocaine in acute rotator cuff tendinitis. Br J Rheumatol (1993) 1.26
Calcific tendinitis of the shoulder. N Engl J Med (1999) 1.25
Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Arthritis Rheum (2001) 1.24
Immunological and histological study of temporal arteries. Ann Rheum Dis (1978) 1.24
Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J (2005) 1.23
Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA. Postgrad Med J (1992) 1.23
Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. J Cell Sci (1986) 1.22
Frozen shoulder: an arthrographic and radionuclear scan assessment. Ann Rheum Dis (1984) 1.20
Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis (1985) 1.20
Factors relating to circulating immune complexes in rheumatoid arthirits. Ann Rheum Dis (1976) 1.20
Differential Toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis (2008) 1.19
Shoulder pain in a community-based rheumatology clinic. Br J Rheumatol (1995) 1.17
The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol (2001) 1.16
Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum (2003) 1.15
A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans. Clin Exp Immunol (1996) 1.15
Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro. J Hand Surg Br (2001) 1.14
Long-term azathioprine in rheumatoid arthritis: a double-blind study. Ann Rheum Dis (1981) 1.13
Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arthritis Rheum (2001) 1.13
Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis (1981) 1.13
Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid. Biochim Biophys Acta (1982) 1.13
Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol (1996) 1.12
Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye (Lond) (1995) 1.12
Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population. Clin Exp Immunol (1993) 1.10
Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum (2006) 1.10
The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor. Biochem Biophys Res Commun (1994) 1.10
Arthro-osteitis--a clinical spectrum. Br J Rheumatol (1993) 1.10
The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens. Ann Rheum Dis (1982) 1.09
The analgesic effects of subhypnotic doses of propofol in human volunteers with experimentally induced tourniquet pain. AANA J (2001) 1.08
Prevalence and possible pathological significance of calcium phosphate salt accumulation in tendon matrix degeneration. Ann Rheum Dis (1996) 1.08